iPS Cells & Regenerative Medicine Weekly Report July 19, 2026

iPS Cells & Regenerative Medicine Weekly Report July 26, 2026

Global Leukapheresis Market Growth Accelerates Driven by Cell Therapy, Oncology, and Transplant Demand

Bone Biologics Reports Development Progress in Bone Regeneration, Secures $1.6M from Warrant Exercise

Roche Discontinues Lupus TCE Development, Retains Strong Interest in Autoimmune Cell Therapy

Instinct Bio Debuts on Nasdaq Following SPAC Merger, Infusing New Capital into Cell and Gene Therapy Sector

First-in-Human Diabetes Cell Therapy Shows Promising Initial Clinical Data

Long-Term Safety of iPS Cell Therapy for Spinal Cord Injury Confirmed in Japan

Qatar Issues Stark Warning Against Unapproved Injectable Exosomes, Citing Lack of Scientific Basis and Safety Data